|
Trochim
46
|
Wiist
42
|
Jahiel
9
|
Stillman
45
|
Sacks
37
|
Baum
50
|
Mialon
40
|
Ulucanlar
47
|
Knai
51
|
Madureira Lima
17
|
McCambridge
18
|
Keshavarz Mohammadi
49
|
Wood
41
|
Legg
36
|
Political environment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lobbying |
•
|
•
|
•
|
•
|
•
|
•
|
•
|
•
|
|
•
|
•
|
|
•
|
•
|
Political donations |
•
|
•
|
•
|
•
|
•
|
|
•
|
•
|
•
|
•
|
•
|
|
•
|
|
Direct participation in policy-making via government agencies and partnerships |
•
|
•
|
•
|
•
|
|
|
•
|
•
|
•
|
•
|
•
|
|
•
|
•
|
Revolving doors |
|
|
•
|
|
|
|
•
|
|
|
•
|
|
|
•
|
|
Policy substitution |
•
|
|
|
•
|
|
|
•
|
|
|
|
|
|
•
|
|
Promote self-regulation or de-regulation |
•
|
|
•
|
•
|
•
|
|
|
•
|
•
|
|
|
|
•
|
|
Involvement in international trade negotiations |
|
•
|
|
•
|
|
•
|
•
|
|
|
•
|
•
|
|
•
|
•
|
Pressures on national governments |
|
|
|
•
|
|
•
|
•
|
•
|
|
|
|
|
•
|
|
Tax avoidance |
|
|
|
•
|
|
|
|
|
|
•
|
|
|
|
|
Tied development aid |
|
|
|
|
|
|
|
|
|
•
|
|
|
|
|
Pressures on international organisations |
|
|
|
•
|
|
|
|
|
|
•
|
|
|
|
|
Portfolio diversification |
|
|
|
•
|
|
|
|
|
|
|
|
|
|
|
Preference Shaping
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate social responsibility |
•
|
•
|
•
|
•
|
•
|
•
|
•
|
|
•
|
•
|
•
|
•
|
•
|
|
Marketing and advertising |
•
|
•
|
•
|
•
|
•
|
•
|
|
|
•
|
•
|
•
|
|
•
|
|
Product modification and targeting vulnerable populations |
•
|
|
•
|
•
|
•
|
•
|
|
|
|
|
|
|
•
|
|
Product amount and concentration |
|
|
•
|
•
|
•
|
•
|
|
|
•
|
|
•
|
|
|
|
Pricing |
|
|
•
|
•
|
•
|
|
|
|
|
•
|
•
|
|
|
|
Product Availability |
|
|
•
|
|
•
|
•
|
|
|
•
|
|
•
|
|
•
|
|
Civil society capture |
•
|
|
|
•
|
•
|
|
|
|
|
•
|
|
|
•
|
•
|
Capturing of the media |
•
|
|
|
|
|
|
•
|
|
|
•
|
|
|
•
|
•
|
Use of public relations companies |
|
|
•
|
|
|
|
|
•
|
|
•
|
|
|
|
|
Key opinion leaders and funding health organisations |
•
|
|
|
•
|
|
|
•
|
•
|
|
•
|
|
|
|
•
|
Manufacturing doubt |
•
|
|
•
|
•
|
|
|
•
|
•
|
•
|
•
|
•
|
|
•
|
•
|
Issue framing and attention deflection |
•
|
|
•
|
|
|
|
•
|
|
•
|
•
|
|
|
|
•
|
Building business coalitions |
•
|
|
•
|
•
|
•
|
•
|
•
|
|
•
|
|
|
|
|
•
|
Knowledge environment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funding research/academic institutions |
•
|
|
•
|
•
|
•
|
|
•
|
•
|
•
|
•
|
|
|
•
|
•
|
Industry sponsored education |
•
|
|
|
•
|
|
|
•
|
|
|
•
|
•
|
|
•
|
•
|
Scientific advisory boards/science institutes |
•
|
|
|
|
|
|
•
|
•
|
|
•
|
|
|
|
•
|
Suppress publication of unfavourable science |
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
Legal environment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Litigation and pre-emption |
•
|
|
•
|
|
|
•
|
•
|
•
|
|
•
|
•
|
|
•
|
•
|
Liability |
•
|
|
|
|
|
|
|
|
|
•
|
|
|
•
|
•
|
Unregulated activity/externalised costs |
|
•
|
|
|
|
|
|
|
|
•
|
|
|
|
|
Using international activities to avoid domestic regulation |
•
|
|
|
•
|
|
•
|
|
|
|
|
|
|
|
|
Extra-legal environment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate illegal activity |
•
|
|
|
•
|
• |
|
|
• |
• |
•
|
• |
|
•
|
|
Harassment |
•
|
|
|
•
|
|
•
|
|
• |
|
|
|
|
•
|
•
|
Opposition fragmentation |
•
|
|
|
•
|
|
|
• |
• |
|
•
|
|
|
|
|
Tax evasion |
|
|
|
|
|
•
|
|
|
|
•
|
|
|
|
|